Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze PRLD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate PRLD investment potential.

What is PRLD stock price today?

Get real-time PRLD stock price, historical data, and price charts on Financhill. Track PRLD performance with our advanced analysis tools.

Is PRLD a good investment?

Evaluate PRLD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy PRLD stock?

To buy PRLD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of PRLD?

View detailed market capitalization data and company valuation metrics for PRLD on our comprehensive analysis page.

What is the P/E ratio of PRLD?

Use our fundamental analysis tools to view PRLD P/E ratio and compare valuation metrics with industry peers.

What are PRLD earnings?

View PRLD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Prelude Therapeutics, Inc. 10K Form

Sell

PRLD
Prelude Therapeutics, Inc.

Last Price:

$1.45

Seasonality Move:

-0.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-05-11	10Q	PRLD/Prelude Therapeutics, Inc. Quarterly
2021-03-16	10K	PRLD/Prelude Therapeutics, Inc. Annual
2020-11-10	10Q	PRLD/Prelude Therapeutics, Inc. Quarterly

Receive PRLD News And Ratings

See the #1 stock for the next 7 days that we like better than PRLD

PRLD Financial Statistics

Sales & Book Value

Annual Sales:	$7M
Cash Flow:	$-19.1M
Price / Cash Flow:	0
Annual Sales:	$1.03
Price / Book:	1.57

Profitability

EPS (TTM):	-1.61330
Net Income (TTM):	$-111.8M
Gross Margin:	$5.2M
Return on Equity:	-106.36%
Return on Assets:	-77.23%

Prelude Therapeutics, Inc. Earnings Forecast

Key Prelude Therapeutics, Inc. Financial Ratios

The Gross Profit Margin over the past 7 years for PRLD is 74.69%.
The Selling, General & Administrative Expenses for PRLD have been equal to 410.27% of Gross Profit Margin.
The Research & Development expenses have been 1,685.64% of Revenue.
The Net Earning history of PRLD is -1,816.76% of Total Revenues.
Per Share Earnings over the last 7 years have been positive in 2 years.

Prelude Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	PRLD
CUSIP:	74065P
Website:	preludetx.com

Debt

Debt-to-Equity Ratio:	0.31
Current Ratio:	3.21
Quick Ratio:	3.02

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

PRLD Technical Analysis vs Fundamental Analysis